|
|
|
The World Market for Orphan Drugs
6/13/2013 | published by: Kalorama Information
In recent years, there has been a substantial increase in the number of drugs available to treat rare ("orphan") diseases. This comprehensive report, The World Market for Orphan Drugs, looks at this trend and
|
read more...
|
$4,500.00
|
|
The World Market for Pain Management Drugs and Devices
5/20/2013 | published by: Kalorama Information
The World Market for Pain Management Drugs and Devices encompasses a wide variety of products that treat and ease pain. The field of pain management is currently experiencing a busy and interesting period; and
|
read more...
|
$3,500.00
|
|
Triple Analysis: Lung Cancer, Lymphoma and Melanoma
6/12/2013 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in Lung Cancer, Lymphoma and Melanoma. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology
|
read more...
|
$5,175.00
|
|
Lab Automation Market by Equipment & Software (Automated Liquid Handling & Robotics, Microplate Readers, LIMS and Automated Storage), and Applications (Drug Discovery, Clinical Diagnostics, Genomics, Proteomics) – Trends & Global Forecasts to 2017
6/14/2013 | published by: MarketsandMarkets
Lab Automation Market by Equipment & Software (Automated Liquid Handling & Robotics, Microplate Readers, LIMS and Automated Storage), and Applications (Drug Discovery, Clinical Diagnostics, Genomics, Proteomics) – Trends & Global Forecasts to 2017
|
read more...
|
$4,650.00
|
|
Triple Analysis: Lung Cancer, Melanoma and Angiogenesis
6/12/2013 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts is evaluated according to standardized criteria in a
|
read more...
|
$5,175.00
|
|
Triple Analysis: Lung Cancer, Melanoma and Antibodies
6/12/2013 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the compound strategy of Antibodies. Each of these three individual parts is evaluated according to standardized criteria in
|
read more...
|
$5,175.00
|
|
Triple Analysis: Lymphoma, Melanoma and Apoptosis
6/12/2013 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated according to standardized criteria in a five
|
read more...
|
$5,175.00
|
|
Triple Analysis: Melanoma, Prostate Cancer and Peptides
6/12/2013 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in both Melanoma and Prostate Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated according to standardized criteria in
|
read more...
|
$5,175.00
|
|
Triple Analysis: Melanoma, Angiogenesis and Antibodies
6/12/2013 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Antibodies). Each of these three individual parts is evaluated according to
|
read more...
|
$5,175.00
|
|
Analysis of the Sexually-Transmitted Disease Testing Market in the US: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis
6/14/2013 | published by: Venture Planning Group
This new 278-page report from Venture Planning Group, Analysis of the Sexually-Transmitted Disease Testing Market in the US: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis , provides analysis of the US sexually-transmitted disease testing market, including emerging
|
read more...
|
$4,500.00
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Drug Discovery Reports